-
Report paints hopeful picture for retail industry
ALLENTOWN, Pa. — A just-released analysis of the U.S. retail sector offers positive news for an industry that has been subject to some gloomy assessments in recent times.
Despite the rash of recent Chapter 11 filings and store closings, the U.S. retail sector as a whole remains incredibly strong and shows no signs of slowing down, according to a report by business intelligence firm Creditsafe USA.
-
Astellas expands small-molecule drug pipeline with Ogeda acquisition
TOKYO and GODDELIES — Astellas Pharma on Monday announced an acquisition that will expand the company’s late-stage small-molecule pipeline. Astellas will be acquiring drug discovery company Ogeda for as much as €800 million, including a €500 million initial payment. Ogeda shareholders will be eligible for an additional €300 million as the company attains certain clinical milestones for its lead investigational candidate fenzolinetant.